Dr. Kip has experience and interest in managing large observational epidemiological studies and clinical trials, primarily in the areas of cardiovascular diseases, novel psychotherapies, and COVID-19. He also has research interests in psychoneuroimmunology, complementary and alternative medicine, and epidemiological methods.
Fellow -- American Association for the Advancement of Science (FAAAS)